Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
41,000
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,845.80 | 33.10 | 0.38% |
| CAC 40 | 7,804.33 | 12.86 | 0.17% |
| DAX 40 | 23,987.56 | 186.76 | -0.77% |
| Dow JONES (US) | 42,866.87 | 105.11 | 0.25% |
| FTSE 100 | 8,853.08 | 20.80 | 0.24% |
| HKSE | 24,191.32 | 28.45 | 0.12% |
| NASDAQ | 19,714.99 | 123.75 | 0.63% |
| Nikkei 225 | 38,329.79 | 118.28 | 0.31% |
| NZX 50 Index | 12,622.56 | 58.14 | 0.46% |
| S&P 500 | 6,038.81 | 32.93 | 0.55% |
| S&P/ASX 200 | 8,619.50 | 32.30 | 0.38% |
| SSE Composite Index | 3,383.44 | 1.38 | -0.04% |